279 related articles for article (PubMed ID: 1396754)
21. Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam.
Hong HA; Ke NT; Nhon TN; Thinh ND; van der Gun JW; Hendriks JT; Kreeftenberg JG
Bull World Health Organ; 1996; 74(3):275-82. PubMed ID: 8789926
[TBL] [Abstract][Full Text] [Related]
22. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
23. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation.
Sesardic D; Winsnes R; Rigsby P; Behr-Gross ME
Pharmeuropa Bio; 2004 Jan; 2003(2):69-76. PubMed ID: 14960263
[TBL] [Abstract][Full Text] [Related]
24. Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants.
Taranger J; Trollfors B; Lagergård T; Lind L; Sundh V; Zackrisson G; Bryla DA; Robbins JB
Pediatr Infect Dis J; 1997 Feb; 16(2):180-4. PubMed ID: 9041597
[TBL] [Abstract][Full Text] [Related]
25. [Comparative study of the immunoglobulins and specific antibodies in the blood of rabbits immunized with ADTP vaccine and ADT-anatoxin with normal and reduced antigen contents].
Kozlova NN; Gervazieva VB; Il'nitskaia EA; Moshiashvili IIa
Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):39-42. PubMed ID: 3874505
[TBL] [Abstract][Full Text] [Related]
26. Determination of tetanus and diphtheria antitoxin content in dried samples of capillary blood: a convenient method applied to infants.
Schou C; Simonsen O; Heron I
Scand J Infect Dis; 1987; 19(4):445-51. PubMed ID: 3672050
[TBL] [Abstract][Full Text] [Related]
27. Does vaccination ensure protection? Assessing diphtheria and tetanus antibody levels in a population of healthy children: A cross-sectional study.
Gowin E; Wysocki J; Kałużna E; Świątek-Kościelna B; Wysocka-Leszczyńska J; Michalak M; Januszkiewicz-Lewandowska D
Medicine (Baltimore); 2016 Dec; 95(49):e5571. PubMed ID: 27930568
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland.
Zasada AA; Rastawicki W; Rokosz N; Jagielski M
BMC Infect Dis; 2013 Nov; 13():551. PubMed ID: 24252165
[TBL] [Abstract][Full Text] [Related]
29. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
[TBL] [Abstract][Full Text] [Related]
30. IgG and IgG subclass specific antibody responses to diphtheria and tetanus toxoids in newborns and infants given DTP immunization.
Dengrove J; Lee EJ; Heiner DC; St Geme JW; Leake R; Baraff LJ; Ward JI
Pediatr Res; 1986 Aug; 20(8):735-9. PubMed ID: 3737285
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
Maheshwari SC; Sharma SB; Kumar A; Sokhey J
J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
[TBL] [Abstract][Full Text] [Related]
32. [Immunity against diphtheria and tetanus in the adult Polish population].
Walory J; Grzesiowski P; Hryniewicz W
Pol Merkur Lekarski; 2000 Oct; 9(52):687-92. PubMed ID: 11144058
[TBL] [Abstract][Full Text] [Related]
33. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.
Claesson BA; Schneerson R; Lagergård T; Trollfors B; Taranger J; Johansson J; Bryla D; Robbins JB
Pediatr Infect Dis J; 1991 Aug; 10(8):560-4. PubMed ID: 1891286
[TBL] [Abstract][Full Text] [Related]
34. [Immunogenicity and safety of a tetanus-diphtheria vaccine (adult type): clinical trial in adults].
Gil A; Dal-Ré R; González A; Lasheras L; Aguilar L; del Rey J
Med Clin (Barc); 1995 Feb; 104(4):126-9. PubMed ID: 7898155
[TBL] [Abstract][Full Text] [Related]
35. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
[TBL] [Abstract][Full Text] [Related]
36. [Diphtheria booster immunization for adults].
Hasselhorn HM; Nübling M; Tiller FW; Hofmann F
Dtsch Med Wochenschr; 1997 Mar; 122(10):281-6. PubMed ID: 9102270
[TBL] [Abstract][Full Text] [Related]
37. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
[TBL] [Abstract][Full Text] [Related]
38. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
Al Aswad IH; Shubair ME
East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
[TBL] [Abstract][Full Text] [Related]
40. Immune status and booster effects of low doses of tetanus toxoid in Swedish medical personnel.
Björkholm B; Wahl M; Granström M; Hagberg L
Scand J Infect Dis; 1994; 26(4):471-5. PubMed ID: 7984981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
